Hirosaki LI announces that it has acquired the marketing authorization for the human (autologous) oral mucosa-derived epithelial cell sheet using human amniotic membrane substrate (brand name: Sakracy) as a regenerative medical product for the alleviation of adhesion on the ocular surface accompanying limbal stem cell deficiency in Japan.

ヒト羊膜基質使用ヒト（自己）口腔粘膜由来上皮細胞シート（販売名「サクラシー」）製造販売承認取得に関するお知らせ